Interleukin-1β enhances susceptibility to hyperthermia-induced seizures in developing rats

Seizure

Volumn 18, Issue 3, 2009, Pages 211-214

  Fukuda, Mitsumasa ^a   Suzuki, Yuka ^a   Ishizaki, Yoshito ^b   Kira, Ryutaro ^b   Kikuchi, Chiya ^a   Watanabe, Shohei ^a   Hino, Hitomi ^a   Morimoto, Takehiko ^c   Hara, Toshiro ^b   Ishii, Eiichi ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Ehime Rehabilitation Center for Children   (Japan)

Author keywords

Cytokine; Febrile; Hyperthermia; Interleukin 1 ; Rat; Seizure

Indexed keywords

HUMAN RECOMBINANT INTERLEUKIN 1 BETA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 1; SODIUM CHLORIDE; UNCLASSIFIED DRUG; INTERLEUKIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TEMPERATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTROENCEPHALOGRAPHY; HYPERTHERMIA; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; ANIMAL; BODY TEMPERATURE; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; FEVER; INTRANASAL DRUG ADMINISTRATION; LEWIS RAT; METABOLISM; METHODOLOGY; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REACTION TIME;

ADMINISTRATION, INTRANASAL; ANIMALS; ANIMALS, NEWBORN; BODY TEMPERATURE; BRAIN; DISEASE SUSCEPTIBILITY; ELECTROENCEPHALOGRAPHY; FEVER; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; RATS; RATS, INBRED LEW; REACTION TIME; RECEPTORS, INTERLEUKIN-1; SEIZURES;

EID: 61349159237     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2008.10.001     Document Type: Article

References (31)

1. Camfield C., and Camfield P. Febrile seizures. In: Rojer J., Bureau M., Dravet C., Genton P., Tassinari C.A., and Wolf P. (Eds). Epileptic syndromes in infancy, childhood and adolescence. 4th ed. (2005), John Libbey Eurotext, Montrouge 159-169
2. Cendes F., Kahane P., Brodie M., and Andermann F. The mesio-temporal lobe epilepsy syndrome. In: Rojer J., Bureau M., Dravet C., Genton P., Tassinari C.A., and Wolf P. (Eds). Epileptic syndromes in infancy, childhood and adolescence. 4th ed. (2005), John Libbey Eurotext, Montrouge 555-575
3. Peltola J., Palmio J., Korhonen L., Suhonen J., Miettinen A., Hurme M., et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Research 41 (2000) 205-211
4. Virta M., Hurme M., and Helminen M. Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 43 (2002) 920-923
5. Hulkkonen J., Koskikallio E., Rainesalo S., Keränen T., Hurme M., and Peltola J. The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy Research 59 (2004) 199-205
6. Lehtimäki K.A., Keränen T., Huhtala H., Hurme M., Ollikainen J., Honkaniemi J., et al. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. Journal of Neuroimmunology 152 (2004) 121-125
7. Haspolat S., Mihçi E., Coskun M., Gümüslü S., Özbenm T., and Yegin O. Interleukin-1β, tumor necrosis factor-α, and nitrite levels in febrile seizures. Journal of Child Neurology 17 (2002) 749-751
8. Vezzani A., Moneta D., Ricichi C., Perego C., and De Simoni M.G. Functional role of proinflammatory and anti-inflammatory cytokines in seizures. Advances in Experimental Medicine and Biology 548 (2004) 123-133
9. Kira K., Torisu H., Takemoto M., Nomura A., Sakai Y., Sanefuji M., et al. Genetic susceptibility to simple febrile seizures: Interleukin-1β promoter polymorphisms are associated with sporadic cases. Neuroscience Letter 384 (2005) 239-244
10. Haspolat S., Baysal Y., Duman O., Coskun M., Tosun O., and Yegin O. Interleukin-1α, interleukin-1β, and interleukin-1ra polymorphisms in febrile seizures. Journal of Child Neurology 20 (2005) 565-568
11. Fukuda M., Morimoto T., Nagao H., and Kida K. Clinical study of epilepsy with severe febrile seizures and seizures induced by hot water bath. Brain & Development 19 (1997) 212-216
12. Millichap J.G. Studies in febrile seizures. 1. Height of body temperatures as a measure of the febrile seizure threshold. Pediatrics 23 (1959) 76-85
13. Hjeresen D.L., and Diaz J. Ontogeny of susceptibility to experimental febrile seizures in rats. Developmental Psychobiology 21 (1988) 261-275
14. Morimoto T., Nagao H., Sano N., Takahashi M., and Matsuda H. Electroencephalographic study of rat hyperthermic seizures. Epilepsia 32 (1991) 289-293
15. Baram T.Z. Febrile seizures: an appropriate-aged model suitable for long-term studies. Developmental Brain Research 98 (1997) 265-270
16. Dubé C., Vezzani A., Behrens M., Bartfai T., and Baram T.Z. Interleukin-1β contributes to the generation of experimental febrile seizures. Annals of Neurology 57 (2005) 152-155
17. Sayyah M., Beheshti S., Shokrgozar M.A., Eslami-far A., Deljoo Z., Khabiri A.R., et al. Antiepileptogenic and anticonvulsant activity of interleukin-1β in amygdala-kindled rats. Experimental Neurology 191 (2005) 145-153
18. Kalueff A.V., Lehtimaki K.A., Ylinen A., Honkaniemi J., and Peltola J. Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neuroscience Letter 365 (2004) 106-110
19. Heida J.G., and Pittman Q.J. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia 46 (2005) 1906-1913
20. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proceeding of the National Academy of Sciences of the United States of America 21 (2000) 11534-11539
21. A) receptor current in cultured hippocampal neurons. The Journal of Pharmacology and Experimental Therapeutics 292 (1999) 497-504
22. Fukuda M., Morimoto T., Nagao H., and Kida K. The effect of GABAergic system activity on hyperthermia-induced seizures in rats. Developmental Brain Research 104 (1997) 197-199
23. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., et al. Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. The Journal of Neuroscience 24 (2003) 8692-8700
24. Morimoto T., Kida K., Nagao H., Yoshida K., Fukuda M., and Takashima S. The pathogenic role of the NMDA receptor in hyperthermia-induced seizures in developing rats. Developmental Brain Research 84 (1995) 204-207
25. Vezzani A., and Baram T.Z. New roles for interleukin-1 beta in the mechanisms of epilepsy. Epilepsy Currents 7 (2007) 45-55
26. Romijn H.J., Hofman M.A., and Gramsbergen A. At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby?. Early Human Development 26 (1991) 61-67
27. Lawrence D. Intranasal delivery could be used to administer drugs directly to the brain. Lancet 359 (2002) 1674
28. Dufes C., Olivier J.C., Gaillard F., Gaillard A., Couet W., and Muller J.M. Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats. International Journal of Pharmaceutics 255 (2003) 87-97
29. Fukuda M., Morimoto T., Suzuki Y., Shinonaga C., and Ishida Y. Interleukin-6 attenuates hyperthermia-induced seizures in developing rats. Brain & Development 10 (2007) 644-648
30. Begley D.J. The blood-brain barrier: principles for targeting peptide and drugs to the central nervous system. The Journal of Pharmacy and Pharmacology 48 (1996) 136-146
31. Dubé C., Chen K., Eghbal-Ahmadi M., Brunson K., Soltesz I., and Baram T.Z. Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term. Annals of Neurology 47 (2000) 336-344